Tandem Diabetes Care (TNDM) Times Interest Earned (2013 - 2026)
Tandem Diabetes Care (TNDM) posted Times Interest Earned of -$0.1 for Q1 2026, down 118.57% on a QoQ basis from $0.55 in Q4 2025, and up 99.2% year-over-year from -$0.05 in Q1 2025.
Tandem Diabetes Care (TNDM) Times Interest Earned (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's Times Interest Earned history runs 14 years deep, the most recent figure standing at -$0.1 for Q1 2026.
- Quarterly Times Interest Earned rose 99.2% year-over-year to -$0.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.49 (up 97.4% YoY) and the FY2025 annual result came in at -$0.69, down 47.04% from the prior year.
- Times Interest Earned was -$0.1 for Q1 2026 at Tandem Diabetes Care, down from $0.55 in the prior quarter.
- Across five years, Times Interest Earned topped out at $0.55 in Q4 2025 and bottomed at -$83.81 in Q1 2023.
- A 5-year average of -$10.85 and a median of -$3.43 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned sank 3538.61% — and 2024, when it surged 104.48%.
- Tandem Diabetes Care's Times Interest Earned stood at -$0.59 in 2022, then slumped by 924.43% to -$6.02 in 2023, then surged by 104.48% to $0.27 in 2024, then jumped by 104.38% to $0.55 in 2025, then sank by 118.57% to -$0.1 in 2026.
- Business Quant data shows TNDM's Times Interest Earned at -$0.1 in Q1 2026, $0.55 in Q4 2025, and -$3.43 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | -0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | 0.55 |
| Sep 30, 2025 | -3.43 |
| Jun 30, 2025 | -0.28 |
| Mar 31, 2025 | -12.86 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | -2.78 |
| Jun 30, 2024 | -3.27 |
| Mar 31, 2024 | -4.43 |
| Dec 31, 2023 | -6.02 |
| Sep 30, 2023 | -6.52 |
| Jun 30, 2023 | -24.18 |
| Mar 31, 2023 | -83.81 |
| Dec 31, 2022 | -0.59 |
| Sep 30, 2022 | -30.14 |
| Jun 30, 2022 | -2.37 |
| Mar 31, 2022 | -4.51 |
| Dec 31, 2021 | 5.91 |
| Sep 30, 2021 | 0.88 |
| Jun 30, 2021 | 0.62 |